Oxford Instruments PLC
LSE:OXIG
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1 938
2 660
|
| Price Target |
|
We'll email you a reminder when the closing price reaches GBX.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Oxford Instruments PLC
Oxford Instruments PLC
Total Receivables
Oxford Instruments PLC
Total Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Oxford Instruments PLC
LSE:OXIG
|
Total Receivables
£115.7m
|
CAGR 3-Years
14%
|
CAGR 5-Years
7%
|
CAGR 10-Years
4%
|
|
|
Renishaw PLC
LSE:RSW
|
Total Receivables
£175.6m
|
CAGR 3-Years
9%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Spectris PLC
LSE:SXS
|
Total Receivables
£300.5m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
4%
|
|
|
Halma PLC
LSE:HLMA
|
Total Receivables
£463.5m
|
CAGR 3-Years
20%
|
CAGR 5-Years
12%
|
CAGR 10-Years
13%
|
|
|
S
|
SDI Group PLC
LSE:SDI
|
Total Receivables
£12.8m
|
CAGR 3-Years
24%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
26%
|
|
|
Synectics PLC
LSE:SNX
|
Total Receivables
£18.9m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-5%
|
|
Oxford Instruments PLC
Glance View
Oxford Instruments PLC, a pioneer in scientific technology, has carved a niche in the industry by bridging the gap between complex scientific research and practical application. Founded in 1959 by Sir Martin Wood, the company initially focused on superconducting magnets, which played a crucial role in the advancement of MRI technology. Fast forward to today, Oxford Instruments is a diversified, high-tech group supplying tools and systems that drive innovation across multiple sectors. From materials science and semiconductors to quantum technologies and healthcare, the company designs and manufactures instrumentation and components that allow scientists and engineers to explore the natural world’s smallest details. The heart of Oxford Instruments' business lies in its commitment to enabling customers to measure and manipulate matter at the micro and nano level, providing insights that advance fundamental research, improve manufacturing processes, and drive product quality and performance. The financial lifeline of Oxford Instruments stems from its broad portfolio of products and services that encompass everything from cutting-edge nanoanalysis tools to industrial analysis equipment and superconductors. The company's revenue streams are diversified across various industries and geographical segments, providing a stable base despite cyclical fluctuations in any single market. With an emphasis on R&D, Oxford Instruments continuously evolves its offerings, ensuring products remain at the forefront of scientific advancements. Its collaborative approach with academic institutions and commercial partnerships further enhances its ability to deliver innovative solutions tailored to the specific demands of its client base. Through this combination of innovation, diversification, and collaboration, Oxford Instruments not only sustains its financial health but also consistently contributes to advancements that shape the future of technology and industry.
See Also
What is Oxford Instruments PLC's Total Receivables?
Total Receivables
115.7m
GBP
Based on the financial report for Mar 31, 2024, Oxford Instruments PLC's Total Receivables amounts to 115.7m GBP.
What is Oxford Instruments PLC's Total Receivables growth rate?
Total Receivables CAGR 10Y
4%
Over the last year, the Total Receivables growth was 2%. The average annual Total Receivables growth rates for Oxford Instruments PLC have been 14% over the past three years , 7% over the past five years , and 4% over the past ten years .
You don't have any saved screeners yet